Wednesday, April 23, 2025

6:30 PM to 9:00 PM Central Time
 
Myeloproliferative Neoplasms (MPNs) Rounds Chicago
Crowne Plaza West Loop
West Loop Ballroom D
25 South Halsted Street
Chicago, IL 60661
 
*Practicing healthcare professionals: LLS will cover self-parking. At the end of Rounds, upon submission of your completed program evaluation and feedback forms, LLS will provide a voucher for parking. 
 
*Only one (1) person per medical technology/pharmaceutical company may register and attend the MPN rounds. A corporate email address is required.
 

Agenda

6:30 PM – Dinner and Networking
7:00 PM – Welcome and Overview of Program
Olatoyosi Odenike
7:05 PM – Overview of LLS Resources
LLS Staff
7:15 PM – Case Presentation and Discussion on Polycythemia Vera (PV): To Interfer-on or Not? Indications and Options for Cytoreductive Therapy in PV
Jamile M. Shammo and Juan Alban
7:45 PM – Case Presentation and Discussion on Management of Myelofibrosis (MF) with the Use of JAK Inhibitors
Anand A. Patel, Irum Khan, and Rafael Madero Marroquin
8:15 PM – Case Presentation and Discussion on the Contemporary Approach to Stem Cell Transplantation for Patients with MPN/MF
Satyajit Kosuri, Stephanie B. Tsai, and Benjamin Massat
8:45 PM – Q&A, Discussion and Wrap-up
All Faculty
9:00 PM – Conclusion
Olatoyosi Odenike
 
 
 

Description

Live interactive continuing medical education activity for healthcare professionals in Chicago and surrounding areas to discuss myeloproliferative neoplasms (MPNs) updates and challenges in treatment.

Target Audience

This activity is intended for hematologists-oncologists, medical oncologists, physician associates, advanced practice providers, nurses and pharmacists involved in the care of patients with myeloproliferative neoplasms (MPNs).

Educational Objectives

After completing this activity, participants will be better able to:
  • Explain the latest treatment options for myeloproliferative neoplasms (MPNs), including updates on clinical trials
  • Identify disparities and challenges in diagnosis and treatment of MPNs
  • Describe side effects of treatment and management strategies
  • Apply diagnostic criteria for a correct diagnosis and grade
  • Identify resources for patient education and support 

Advisory Group

Olatoyosi Odenike, MD, FASCO (Chair)
The University of Chicago
Chicago, IL
 
Noah Birch, MD, PhD
University of Illinois Chicago (UIC)
Chicago, IL
 
Lynne Kaminer, MD
University of Chicago Medical Center
Chicago, IL
 
Irum Khan, MD, MS
Northwestern University 
Evanston, IL
 
Satyajit Kosuri, MD
University of Chicago
Chicago, IL
 
Melissa L. Larson, MD
Rush University Medical Center
Chicago, IL
 
Anand A. Patel, MD
University of Chicago
Chicago, IL
 
Jamile M. Shammo, MD, FASCP, FACP 
Northwestern University Feinberg School of Medicine  
Chicago, IL
 
Stephanie B. Tsai, MD
Loyola University Medical Center
Maywood, IL
 

Faculty

Olatoyosi Odenike, MD, FASCO (Chair)
The University of Chicago
Chicago, IL
 
Juan Alban, MD
Northwestern Memorial Hospital
Chicago, IL
 
Irum Khan, MD, MS
Northwestern University 
Evanston, IL
 
Satyajit Kosuri, MD
University of Chicago
Chicago, IL
 
Rafael Madero Marroquín, MD
University of Chicago
Chicago, IL
 
Benjamin Massat, DO
Loyola University Medical Center
Maywood, IL
 
Anand A. Patel, MD
University of Chicago
Chicago, IL
 
Jamile M. Shammo, MD, FASCP, FACP 
Northwestern University Feinberg School of Medicine  
Chicago, IL
 
Stephanie B. Tsai, MD
Loyola University Medical Center
Maywood, IL
 
This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute Inc, in collaboration with the Association of Cancer Care Centers™ (ACCC).
 
Supported by an educational grant from Karyopharm Therapeutics.
 

For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: Profeducation@LLS.org.

 

Follow LLS